- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Jeff Dale2023-09-14T16:09:00
A Texas-based dermatology management company agreed to pay nearly $8.9 million to settle allegations by the Department of Justice (DOJ) regarding apparent violations of the False Claims Act.
The settlement total agreed to by Oliver Street Dermatology Management, doing business as U.S. Dermatology Partners (USDP), includes approximately $5.9 million in restitution, U.S. Attorney for the Northern District of Texas Leigha Simonton announced in a press release Wednesday.
Between January 2013 and July 2018, USDP acquired multiple dermatology practices across the United States. In September 2021, the company voluntarily self-disclosed to the DOJ credible evidence that former senior managers offered or agreed to increase the purchase price of 11 acquired dermatology practices in exchange for referrals to USDP-affiliated entities following the acquisition, the DOJ alleged. Claims for some of those services were later submitted to Medicare for payment, the DOJ found.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
New guidance from the Department of Health and Human Services is designed to apply generally to the healthcare industry, from doctors to pharmaceutical manufacturers, and help all such entities self-monitor their compliance and prevent waste, fraud, and abuse.
Pharmaceuticals firm Nostrum Laboratories and its founder and chief executive officer could pay up to $50 million as part of a settlement with the Department of Justice addressing alleged violations of the False Claims Act by underpaying Medicaid rebates.
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
